Compare ASUR & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASUR | OABI |
|---|---|---|
| Founded | 1985 | 2012 |
| Country | United States | United States |
| Employees | N/A | 114 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.1M | 253.4M |
| IPO Year | 1996 | N/A |
| Metric | ASUR | OABI |
|---|---|---|
| Price | $8.98 | $1.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.00 | $6.67 |
| AVG Volume (30 Days) | 167.3K | ★ 283.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $88,952,000.00 | N/A |
| Revenue This Year | $16.29 | $74.84 |
| Revenue Next Year | $9.17 | $40.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 63.39 | N/A |
| 52 Week Low | $6.80 | $1.22 |
| 52 Week High | $11.47 | $3.33 |
| Indicator | ASUR | OABI |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 46.37 |
| Support Level | $7.85 | $1.68 |
| Resistance Level | $10.00 | $1.89 |
| Average True Range (ATR) | 0.55 | 0.11 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 75.26 | 26.92 |
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.